Accessibility Tools

Skip to main content

Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series

14 November 2021

Leon D. Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, Berit Jordan, Jan Purrucker, Carmen Haubner, Corinna Seliger, Hanns-Martin Lorenz, Simon Nagel, Brigitte Wildemann, Martin Bendszus, Wolfgang Wick, Silvia Schönenberger

"Population-based studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may trigger immune-mediated thrombotic thrombocytopenia (VITT) raising concerns for other autoimmune responses. The aim was to characterize neurological autoimmunity after SARS-CoV-2 vaccinations."-

Read full article:

Kaulen, LD, Doubrovinskaia, S, Mooshage, C, et al. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur J Neurol. 2021; 00: 1– 9. https://doi.org/10.1111/ene.15147

ene.15147